• No se han encontrado resultados

ESTUDIO DE UN MOSQUERO MAS ECOLOGICO

TEMA 3: CONTROL DE LA MOSCA DEL OLIVO

aEPI 2000, Center Disease Control bMatlab, Mathworks Inc.

cMarkov Chain Add-in for Excel Spreadsheets, Jensen, P.A., Bard, J. Operations

Research Models and Methods, University of Texas.

d SAS v 8.0, SAS Institute, Cary, NC.

3.6 References

Agresti, A., 1996. Likelihood-ratio statistic. In: An Introduction to Categorical Data Analysis, John Wiley and Sons, New York pp.28-30

Al-Sarraf, R., Mauldin, G.N., Patnaik, A.K., Meleo, K.A., 1996. A prospective study of radiation therapy for the treatment of grade 2 mast cell tumors in 32 dogs. J Vet Int Med, 10, 376-378

Anderson, W.J., 1991. Continuous Time Markov Chains. Springer-Verlag, New York. Aoki, N., Kajiyama, T., Beck, R., Cone, R.W., Soma, K., Fukui, T. 2000. Decision analysis of prophylactic treatment for patients with high-risk esophageal varices. Gastrointest Endosc, 52, 707-714

Bauerle, R., Rucker, A., Schmandra, T.C., Holzer, Encke, A., Hanisch, E., 2000. Markov cohort simulation study reveals evidence for sex-based risk difference in intensive care unit patients. Am J Surg, 179, 207-211

Beck, J.R., Pauker, S.G., 1983. The Markov process in medical prognosis. Med Decis Making, 3, 419-458

Blackwood, L., Dobson, J.M., 1996. Radiotherapy of oral malignant melanoma in dogs. J Am Vet Med Assoc, 209, 98-102

Bowling, A., 1995. Measuring Disease: A Review of Disease-Specific Quality Of Life Measurement Scales. Open University Press, Buckingham.

Bowling, A., 1997. Measuring Health: A Review of Quality of Life Measurement Scales. 2nd ed. Open University Press, Buckingham.

Bradlyn, A.S., Pollock, B.H., 1996. Quality-of-life research in the pediatric oncology group: 1991-1995. J Natl Cancer Institute Mono, 20, 49-53

Briggs, A., Sculpher, M., 1998. An introduction to Markov modeling for economic evaluation. Pharmacoeconomics, 13, 397-409

Brown, R.F., Brown, B.W., 1990a. Absorbing Markov Chains. In: Essentials of Finite Mathematics: Matrices, Linear Programming, Probability, Markov Chains, Ardsley House, New York pp.399-412

Brown, R.F., Brown, B.W., 1990b. The Fundamental Matrix. In: Essentials Of Finite Mathematics: Matrices, Linear Programming, Probability, Markov Chains, Ardsley House, New York pp.412-423

Casella, G., Berger, R.L., 1990. Discrete distributions. In: Statistical Inference, Duxbury Press, Belmont pp.85-99

Collett, D., 1994. Modeling Survival Data in Medical Research. CRC Press, Boca Raton.

Craig, B.A., Sendi, P.P., 2001. Estimation of the transition matrix of a discrete-time Markov chain. Health Econ, 11, 33-42

Dunn, G., 1989. Measures of proximity, agreement and disagreement. In: Dunn G, ed. Design and Analysis of Reliability Studies, Oxford University Press, New York pp.19-39

Dunning, D., Monnet, E.R., Orton, E.C., Salman, M.D., 1998. Analysis of prognostic indicators for dogs with pericardial effusion: 46 cases (1985-1996). J Am Vet Med Assoc, 212, 1276-1280

Esik, O., Tusnady, G., Daubner, K., Nemeth, G., Fuzy, M., Szentirmay, Z., 1997. Survival chance in papillary thyroid cancer in Hungary: individual survival probability estimation using the Markov method. Radiotherapy and Oncology, 44, 203-212

Frimberger, A.E., 2000. Experimental treatment options for canine lymphoma. Veterinary Cancer Newsletter, 24, 4-8

Glasziou, P.P., Cole, B.F., Gelber, R.D., Simes, R.J., 1998. Quality adjusted survival analysis with repeated quality of life measures. Stat Med, 17, 1215-1229

Gobar, G.M., Case, J.T., Kass, P.H., 1998. Program for surveillance of causes of death of dogs, using the Internet to survey small animal veterinarians. J Am Vet Med Assoc, 213, 251-256

Hahn, K.A., Richardson, R.C., Teclaw, R.F., Cline, J.M., Carlton, W.W., DeNicola, D.B., Bonney, P.L., 1992. Is maintenance chemotherapy appropriate for the

management of canine lymphoma. J Vet Int Med, 6, 3-10

Hammer, A.S., Weeren, F.R., Weisbrode, S.E., Padgett, S.L., 1995. Prognostic factors in dogs with osteosarcomas of the flat or irregular bones. J Am Anim Hosp Assoc, 31, 321-326

Hendriks, J.C.M., Satten, G.A., Longin, I.M., van Druten, H.A.M., Schellekens, P.T.A., Coutinho, R.A., van Griensven, G.J.P., 1996. Use of immunological markers and continuous-time Markov models to estimate progression of HIV infection in homosexual men. AIDS, 10, 649-656

Hillis, A., Maguire, M., Hawkins, B.S., Newhouse, M.M., 1986. The Markov process as a general method for nonparametric analysis of right-censored medical data. J Chron Disease, 39, 595-604

Hogg, R.V., Craig, A.T., 1995. Expectation or a random variable. In: Introduction to Mathematical Statistics, Prentice-Hall, Upper Saddle River pp.52-67

Hosgood, G., Scholl, D.T., 2000. The effect of different methods of accounting for observations from euthanized animals on survival analysis. Prev Vet Med, 48, 143- 154

Jain, S., 1986. Markov chain model and its applications. Comp Biomed Res, 19, 374- 378

Johnson, K.A., Powers, B.E., Withrow, S.J., Sheetz, M.J., Curtis, C.R., Wrigley, R.H., 1989. Splenomegaly in dogs: Predictors of neoplasia and survival after splenectomy. J Vet Int Med, 3, 160-166

Kalbfleisch, J.D., Lawless, J.F., 1985. The analysis of panel data under a Markov assumption. J Am Stat Assoc, 80, 863-871

Kay, R., 1986. A Markov model for analysing cancer markers and disease states in survival studies. Biometrics, 42, 855-865

Khanna, C., Lund, E.M., Redic, K.A., Hayden, D.W., Bell, F.W., Goulland, E.L., Klausner, J.S., 1998. Randomized controlled trial of doxorubicin versus dactinomycin in a multiagent protocol for treatment of dogs with malignant lymphoma. J Am Vet Med Assoc, 213, 985-990

Kuntz, C.A., Dernell, W.S., Powers, B.E., Devitt, C., Straw, R.C., Withrow, S.J., 1997. Prognostic factors for surgical treatment of soft-tissue sarcoma in dogs: 75 cases (1986-1996). J Am Vet Med Assoc, 211, 1147-1151

Lee, E.T., 1992a. Chapter 1. Introduction - censored observations. In: Statistical Methods for Survival Data Analysis, 2nd ed. John Wiley and Sons Inc, New York pp.1-7

Lee, E.T., 1992b. Chapter 4. Nonparametric methods of estimating survival functions. In: Statistical Methods for Survival Data Analysis, 2nd ed. John Wiley and Sons Inc, New York pp.66-103

Levy, M.S., Kapatkin, A.S., Patnaik, A.K., Mauldin, G.N., Mauldin, G.E., 1997. Spinal tumors in 37 dogs: Clinical outcome and long-term survival (1987-1994). J Am Anim Hosp Assoc, 33, 307-312

Lucroy, M.D., Madewell, B.R., 1999. Clinical outcome and associated diseases in dogs with leukocytosis and neutrophilia: 118 cases (1996-1998). J Am Vet Med Assoc, 214, 805-807

Lucroy, M.D., Phillips, B.S., Kraegel, S.A., Simonson, E.R., Madewell, B.R., 1998. Evaluation of single-agent mitoxantrone as chemotherapy for relapsing canine lymphoma. J Vet Int Med, 12, 325-329

Mallery, K.F., Freeman, L.M., Harpster, N.K., Rush, J.E., 1999. Factors contributing to the decision for euthanasia of dogs with congestive heart failure. J Am Vet Med Assoc, 214, 1201-1204

Marshall, G., 1990. Multi-state Markov models in survival analysis. Department of Preventative Medicine and Biometrics: University of Colorado, p. 84

Marshall, G., Jones, R.H., 1995. Multi-state models and diabetic retinopathy. Stat Med, 14, 1975-1983

Meerschaert, M.M., 1999. Simulation of probability models. In: Mathematical modeling, 2nd ed. Academic Press, San Diego pp.313-344

Moore, A.S., Ogilivie, G.K., Vail, D.M., 1994. Actinomycin D for reinduction of remission in dogs with resistant lymphoma. J Vet Int Med, 8, 343-344

Myers III, N.C., Moore, A.S., Rand, W.M., Gliatto, J., Cotter, S.M., 1997. Evaluation of a multidrug chemotherapy protocol (ACOPA II) in dogs with lymphoma. J Vet Int Med, 11, 333-339

Neter, J., Wasserman, W., Whitmore, G.A., 1982. Correlation and Covariance. In: Applied Statistics, 2 ed. Allyn and Bacon, Bostom pp.130-136

Ng, A.K., Weeks, J.C., Mauch, P.M., Kuntz, K.M., 1999. Decision analysis on

alternative treatment strategies for favorable-prognosis, early-stage Hodgkin's disease. J Clin Oncol, 17, 3577-3585

Norris, J.R., 1997. Markov Chains. Cambridge University Press, Cambridge. Olschewski, M., Schumacher, M. 1990. Statistical analysis of quality of life data in cancer clinical trials. Stat Med, 9, 749-763

Pitson, G., 2000. Editorial: Perils and pitfalls of clinical trials - experiences from human oncology. J Vet Int Med, 14, 392-394

Rosner, B., 1995. The intraclass correlation coefficient. In: Fundamentals of Biostatistics, Duxbury Press, Belmont pp.517-521

Ruslander, D., Moore, A.S., Gliatto, J.M., L'Heureux, D., Cotter, S.M., 1994. Cytosine arabinose as a single agent for the induction of remission in canine lymphoma. J Vet Int Med, 8, 299-301

Schaubel, D.E., Morrison, H.I., Desmeules, M., Parsons, D., Fenton, S.S.A., 1998. End-stage renal disease projections for Canada to 2005 using Poisson and Markov models. Int J Epidem, 27, 274-281

Sendi, P.P., Bucher, H.C., Craig, B.A., Pfluger, D., Battegay, M., 1999. Estimating AIDS-free survival in a severely immunosuppressed asymptomatic HIV-infected population in the era of antiretroviral triple combination therapy. J Acquir Immune Defic Syndr Hum Retrovirol, 20, 376-381

Silverstein, M.D., Albert, D.A., Hadler, N.M., Ropes, M.W., 1988. Prognosis in SLE: Comparison of Markov model to life table analysis. J Clin Epidemiol, 41, 623-633 Slater, M.R., Geller, S., Rogers, K., 2001. Long-term health and predictors of survival for hyperthyroid cats treated with iodine 131. J Vet Int Med, 15, 47-51

Slawienski, M.J., Mauldin, G.E., Mauldin, G.N., Patnaik, A.K., 1997. Malignant colonic neoplasia in cats: 46 cases (1990-1996). J Am Vet Med Assoc, 211, 878-881 Sonnenberg, F.A., 1985. Comparison of different strategies for treatment of duodenal ulcer. Br Med J Clin Res, 290, 1185-1187

Sonnenberg, F.A., Beck, J.R., 1993. Markov models in medical decision making: a practical guide. Med Decis Making, 13, 322-338

Spodnick, G.J., Berg, J., Rand, W.M., Schelling, S.H., 1992. Prognosis for dogs with appendicular osteosarcoma treated by amputation alone: 162 cases (1978-1988). J Am Vet Med Assoc, 200, 995-999

Stewart, A., Phillips, R., Dempsey, G., 1998. Pharmocotherapy for people with Alzeimer's disease: A Markov-cycle evaluation of five years' therapy using donepezil. Int J of Geriatric Psych, 13, 445-453

Stewart, W.J., 1994. Introduction to the Numerical Solution of Markov Chains. Princeton University Press, Princeton.

Straw, R.C., Powers, B.E., Klausner, J., Henderson, R.A., Morrsion, W.B., McCaw, D.L., Harvey, H.J., Jacobs, R.M., Berg, R.J., 1996. Canine mandibular osteosarcoma: 51 cases (1980-1992). J Am Anim Hosp Assoc, 32, 257-262

Thompson, J.P., Fugent, M.J., 1992. Evaluation of survival times after limb

amputation, with and without subsequent administration of cisplatin, for treatment of appendicular osteosarcoma in dogs: 30 cases (1979-1990). J Am Vet Med Assoc, 200, 531-533

van Vechten, M., Helfand, S.C., Jeglum, K.A., 1990. Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine. J Vet Int Med, 4, 187-191

Zemann, B.I., Moore, A.S., Rand, W.M., G., M., Ruslander, D.M., Frimberger, A.E., Wood, C.A., L'Heureux, D.A., Gliatto, J., Cotter, S.M., 1998. A combination

chemotherapy protocol (VELCAP-L) for dogs with lymphoma. J Vet Int Med, 12, 465-470

Zwahlen, C.H., Lucroy, M.D., Kraegel, S.A., Madewell, B.R., 1998. Results of chemotherapy for cats with alimentary malignant lymphoma: 21 cases (1993-1997). J Am Vet Med Assoc, 213, 1144-1149

CHAPTER 4 MARKOV MODEL TO COMPARE PROGRESSION OF